• Newsletters
  • Gift Membership
Logo Logo
Take Scroll With You Download the app to read our award-winning journalism on the go and stay up-to-date with our notifications.
Get the app Get the app
ANDROID iOS
  • Home
  • Common Ground
  • The India Fix
  • Eco India
  • The Latest
  • The Reel
  • Magazine
  • Video
  • Trending
    • ‘I am still writing for the lonely soul’: At 91, Ruskin Bond looks back at his literary life
    • The first woman who climbed to the top of the world – and vanished
    • ‘Newslaundry’ women employees file defamation suit against commentator Abhijit Iyer Mitra
    • Carved in stone: Gujarat’s rich cosmopolitan legacy in a 15th-century tomb complex
    • Why Estonian writer Jaan Kross’s historical fiction is worth reading in India today
    • Bengaluru: Foxconn factory turns rural town into real estate goldmine
    • Should Joan Didion’s therapy notes to her husband about their daughter have been published?
    • 57% districts facing extreme heat risk: Study
    • Strong case needed to stay Waqf Act, says Supreme Court
    • Readers’ comments: As inheritors of the sanatan dharma, how can we foster a questioning people?
    • Why Ashoka University professor’s arrest has no legal basis
    • Why farmers are at risk as India pushes back against global curbs on deadly insecticide
  • Sections
    • Politics
    • Culture
    • India
    • World
    • Film and TV
    • Music
    • Books and Ideas
    • Business and Economy
    • Science and Technology
    • In Pictures
    • Announcements
    • Bookshop
    • The Field
    • Pulse
    • Elections 2024

moderna

  • Moderna’s Covid-19 vaccine shows 94.5% efficacy against virus, says company

    Moderna’s Covid-19 vaccine shows 94.5% efficacy against virus, says company

    Scroll Staff
    · Nov 16, 2020 · 06:22 pm
  • Coronavirus: US hopes to immunise 20 million in December, says vaccine programme head

    Coronavirus: US hopes to immunise 20 million in December, says vaccine programme head

    Scroll Staff
    · Nov 14, 2020 · 05:25 pm
  • Coronavirus: Vaccine makers Moderna and Pfizer reveal trial blueprint amid calls for transparency

    Coronavirus: Vaccine makers Moderna and Pfizer reveal trial blueprint amid calls for transparency

    Scroll Staff
    · Sep 18, 2020 · 03:01 pm
  • Covid-19: US companies Moderna, Pfizer launch late-stage trials of vaccines

    Covid-19: US companies Moderna, Pfizer launch late-stage trials of vaccines

    Scroll Staff
    · Jul 28, 2020 · 10:20 am
  • Coronavirus: US government doubles spending on vaccine candidate amid surge in cases

    Coronavirus: US government doubles spending on vaccine candidate amid surge in cases

    Scroll Staff
    · Jul 27, 2020 · 02:05 pm
  • Coronavirus: Moderna to start final stage vaccine trial on July 27 after Phase I shows it is safe

    Coronavirus: Moderna to start final stage vaccine trial on July 27 after Phase I shows it is safe

    Scroll Staff
    · Jul 15, 2020 · 01:37 pm
Previous